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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe regulation of hematopoietic stem cells (HSCs) depends on the integration of the multiple signals received from the bone marrow
niche. We show the relevance of the protein tyrosine phosphatase PTPN13 and b-catenin as intracellular signaling molecules to control
HSCs adhesiveness, cell cycling, and quiescence. Lethally irradiated mice transplanted with Lin– bone marrow cells in which PTPN13 or
b-catenin had been silenced showed a significant increase of long-term (LT) and short-term (ST) HSCs. A decrease in cycling cells was also
found, together with an increase in quiescence. The decreased expression of PTPN13 or b-catenin was linked to the upregulation of
several genes coding for integrins and several cadherins, explaining the higher cell adhesiveness. Our data are consistent with the notion
that the levels of PTPN13 and b-cateninmust be strictly regulated by extracellular signaling to regulate HSC attachment to the niche and
the balance between proliferation and quiescence.INTRODUCTION
Contrary to other processes that are mainly restricted to
embryonic development, the differentiation of hemato-
poietic stem cells (HSCs) into the different blood lineages
occurs along the life of the individual. For correct hemato-
poiesis, HSCs must maintain a fine balance between quies-
cence and proliferation, and between self-renewal and
differentiation. The relevance of HSCs in regenerative
medicine is remarkable (Mimeault et al., 2007), and the
possibility of expanding HSCs in vitro, preserving their
multipotency, would be a milestone in this regard. There-
fore, understanding the orchestration of themultiple inter-
cellular and intracellular signaling events that control
HSCs quiescence and self-renewal in vivo should help to
attain this goal.
Adult hematopoiesis occurs in the bone marrow (BM),
and the importance of this niche in the regulation of
HSCs was proposed many years ago (Schofield, 1978).
The BM niche is a complex system formed by different
cellular types that support HSCs (Ugarte and Forsberg,
2013). It is increasingly clear that the BM is not homoge-
nous and that different kinds of niche can be found:
osteoblastic, vascular, and perivascular. The influence of
different types of environments could determine the fate
of HSCs, depending on the body’s requirements (Kiel and
Morrison, 2008). At the endosteal niche, HSCs establish
direct contact with osteoblasts (Nakamura-Ishizu and
Suda, 2013). This interaction seems to be important to
maintain HSC quiescence (Zhang et al., 2003; Ellis et al.,516 Stem Cell Reports j Vol. 5 j 516–531 j October 13, 2015 j ª2015 The A2011). Moreover, osteoblasts produce soluble factors
such as thrombopoietin (TPO) (Yoshihara et al., 2007) or
osteopontin (OPN) (Nilsson et al., 2005), both of which
contribute to the maintenance of HSC quiescence.
BM sinusoidal endothelial cells (BMSECs) define the
vascular niche (Nakamura-Ishizu and Suda, 2013), and
different authors have suggested that these cells contribute
to regulating the balance between the self-renewal and dif-
ferentiation of HSCs (Salter et al., 2009; Butler et al., 2010;
Kobayashi et al., 2010).
Within the perivascular niche, two different types of cell
seem to display niche functions: CXC chemokine ligand 12
(CXCL-12)-abundant reticular cells (CAR cells) and Nestin+
mesenchymal stem cells. CAR cells secrete stem cell factor
(SCF) and CXCL12, also known as SDF-1 (stromal cell-
derived factor-1) (Salter et al., 2009; Butler et al., 2010;
Kobayashi et al., 2010). Nestin+ cells express high levels
of genes involved in the regulation of HSCs, and acute
depletion of these cells impairs HSC homing after irradia-
tion (Me´ndez-Ferrer et al., 2010).
In order to understand howhematopoiesis is regulated, it
is necessary not only to understand the different signals
emanating from the niche (Anthony and Link, 2014), but
also to comprehend the integration of these signals by
HSCs.
Canonical Wnt signaling has been related to the regula-
tion of HSCs homeostasis (Reya et al., 2003), and it has
been reported that a switch toward a non-canonical Wnt
signaling causes stem-cell aging (Florian et al., 2013). b-cat-
enin is the nuclear effector of canonicalWnt signaling, anduthors
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Figure 1. Silencing of PTPN13 or b-Catenin in Mouse Hematopoietic Progenitor Cells Decreases the Number GFP+ in the Bone
Marrow
(A) PTPN13 and b-catenin localization in Lin– cells was analyzed by immunostaining with specific antibodies. Nuclei were identified by
DAPI staining. A representative of three different experiments is shown.
(legend continued on next page)
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it also behaves as a cell adhesion molecule owing to its
interaction with cadherins (Valenta et al., 2012). Although
it has been shown that Wnt/b-catenin is required for
hematopoiesis in Xenopus (Tran et al., 2010), the role of
b-catenin in mammalian hematopoiesis remains highly
controversial (Luis et al., 2012).
We have recently shown that the protein tyrosine phos-
phatase PTPN13 regulates b-catenin stability and function
during in vitromegakaryopoiesis (Sardina et al., 2014). Our
results also show that PTN13 is stabilized upon Wnt
signaling activation, suggesting that PTPN13 is another
important player in the context of canonicalWnt signaling
(Sardina et al., 2014). The deficiency of PTPN13 in mice
increases the in vitro differentiation of CD4+ T cells toward
Th1 and Th2 (Nakahira et al., 2007), which together with
our results (Sardina et al., 2014) suggests that PTPN13
may be an important regulator during hematopoiesis.
In the present work, we studied how the downregulation
of PTPN13 or b-catenin affects in vivo hematopoiesis. We
observed that reduced levels of PTPN13 or b-catenin
increase the frequency of ST-HSCs and LT-HSCs, reduce
cell cycling, and increase quiescence. Reduced levels of
these two proteins are associated with an increased expres-
sion of several genes coding for cell adhesion molecules
(CAMs), explaining the increased adhesiveness. Moreover,
our data show that PTPN13 and b-catenin levels are modu-
lated by mesenchymal cell conditioned medium and
different cytokines involved in the control of HSCs, such
as Wnt, TPO, CXCL-12, or SCF. Accordingly, we suggest
that the regulation of PTPN13 and b-catenin levels in
HSCs in response to extracellular signaling is of paramount
importance in the regulation of HSC adhesion, cell cycling,
and quiescence.RESULTS
Silencing of PTPN13 and b-Catenin in Murine
Hematopoietic Progenitor Cells
Here, we analyzed the effect of downregulating PTPN13
and b-catenin in mouse hematopoietic stem and pro-
genitor cells (HSPCs) during in vivo hematopoiesis. We
have previously shown that PTPN13 and b-catenin interact
and colocalize in megakaryocytic cells (Sardina et al.,(B) Lin– cells were modified with shRNA specific against PTPN13 or b-
carrying cells were identified by GFP expression (n = 4 independent e
(C) No differences were found in the frequency of GFP+ Lin– or GFP+ L
(D and E) Lethally irradiated mice were transplanted with Lin– modified
levels were analyzed in the corresponding downregulated cells by q
different mice).
(F) The frequency of GFP+ cells in different compartments in the mice w
Representative flow cytometry diagrams are shown. Numbers next to
Means ± SD are shown. See also Figure S1.
518 Stem Cell Reports j Vol. 5 j 516–531 j October 13, 2015 j ª2015 The A2014). In mouse BM progenitor cells (Lin– cells), we found
a strong colocalization of the signals of both proteins
(Figure 1A; Figure S1A). Small hairpin RNAs (shRNAs)
against b-catenin or PTPN13 were introduced into mice
Lin– cells by lentiviral infection, and an shRNA against
firefly luciferase was used as a control (Sardina et al.,
2014). Cells bearing the different shRNAs were identified
by GFP expression. During in vitro culture, no differences
were found in the percentage of total GFP+ cells (Figure 1B),
GFP+ Lin– cells, or GFP+ LSK cells (Figure 1C; Figure S1C)
between PTPN13 and b-catenin shRNAs and control cells.
The cells were subsequently transplanted into lethally
irradiated mice, and in vivo hematopoiesis was followed
over 8 weeks after transplantation (Figure S1B). PTPN13
and b-catenin silencing in the mice was checked by
quantitative qRT-PCR (Figure 1D) and by immunoblotting
(Figure 1E) in GFP+ purified cells (Figure S1D). When
we analyzed the percentage of GFP+ cells in the trans-
planted animals, no differences were found in peripheral
blood (PB), thymus, or spleen (Figure 1F). However, in
the BM the percentages of GFP+ and GFP+ Lin– cells
were significantly reduced upon b-catenin and PTPN13
silencing (Figure 1F), suggesting that hematopoietic pro-
genitor cells might be affected by PTPN13 and b-catenin
downregulation.PTPN13 and b-Catenin Silencing Increases
the Number of HSCs
Hematopoietic stem cells (HSCs) are defined by their capac-
ity to sustain the differentiation of all blood lineages
(Osawa et al., 1996). In mice, it is possible to distinguish
different HSC subpopulations on the basis of their surface
markers: long-term HSCs (LT-HSCs), which would display
an unlimited capacity for self-renewal; short-term HSCs
(ST-HSCs), with a limited self-renewal capacity; and
multipotent lympho-myeloid progenitors (LMPPs), which
would not self-renew (Osawa et al., 1996; Morrison and
Weissman, 1994; Morrison et al., 1997).
Lin– cells were purified from the BM of transplanted
mice, GFP+ cells were gated, and different subpopulations
of HSCs and progenitor cells were identified. Intriguingly,
the frequency of LSKs (Figure 2A), LT-HSC, and ST-HSC
(Figure 2B) subpopulations increased upon PTPN13 orcatenin, an shRNA against luciferase was used as a control. shRNA-
xperiments).
SK cells during in vitro culture (n = 4 independent experiments).
cells. Spleen GFP+ cells were sorted and PTPN13 or b-catenin mRNA
RT-PCR (n = 4 different mice) (D) and immunoblotting (E) (n = 3
as analyzed 8 weeks after transplantation (n = 5–8 different mice).
boxed areas indicate the percentage of cells in each region.
uthors
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Figure 2. PTPN13 or b-Catenin Silencing Increases the Number of Hematopoietic Stem Cells
In vivo analysis of hematopoiesis in mice transplanted with Lin– control cells (Luc RNAi) or Lin– cells knocked down for PTPN13 or
b-catenin.
(legend continued on next page)
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b-catenin downregulation. When we analyzed more
committed progenitors, no significant differences were
found in LMPPs (Figure 2B), or granulocyte-monocyte
progenitors (GMP) (Figure 2C). However, a significant
decrease in common lymphoid progenitors (CLP), com-
mon myeloid progenitors (CMP), and megakaryocyte-
erythrocyte progenitors (MEPs) was detected (Figure 2C).
Thus, lower levels of PTPN13 or b-catenin led to a reduc-
tion in the total number of engrafted cells, and to a specific
enrichment of the most immature populations (LSKs,
LT-HSCs, and ST-HSCs).
Downregulation of PTPN13 or b-Catenin Increases
Megakaryopoiesis and Lymphopoiesis
In agreement with our recently published in vitro data (Sar-
dina et al., 2014), the silencing of PTPN13 and b-catenin
increased the number of megakaryocytes in vivo (Fig-
ure 2D), which indeed suggests the involvement of these
two proteins in megakarypoiesis. Erythroid cells were
not modified in the BM or in PB, although their numbers
were significantly reduced in spleen (Figure S2A). The
percentage of granulocytes was reduced in peripheral
blood (PB) and spleen, although no differences were
found in bone marrow (BM) when b-catenin or PTPN13
were downregulated. No statistically significant differences
were found in macrophages (Figure S2B).
Several reports suggest the involvement of b-catenin
(Mulroy et al., 2003; Xu and Sen, 2003) and PTPN13 (Naka-
hira et al., 2007) in T cell differentiation. Our data pointed
to a significant decrease in CLPs when PTPN13 or b-catenin
was downregulated (Figure 2C), while the number of CD3+
T cells was significantly upregulated in the thymus and PB
(Figure 2E; Figure S3A). In the thymus, we observed a signif-
icant increase in CD4 (CD4+ CD8–) and CD8 (CD4– CD8+)
single-positive cells (Figure 2F; Figure S3B), which is consis-
tent with the reduction in the DP and DN4 stages of dif-
ferentiation (Figure S3C). Regarding the differentiation of
B cells, we observed an upregulation in spleen when
PTPN13 or b-catenin was downregulated, although no sig-
nificant differences were found in PB or BM (Figure S3D).
No differenceswere found in B cellmaturation (Figure S3E).
In light of the above, our results support the notion of the
involvement of PTPN13 and b-catenin in lymphopoiesis,(A) Identification of LSKs in BM (n = 9–10 different mice).
(B) LT-HSCs, ST-HSCs, LMPPs in BM (n = 8–10 different mice).
(C) Analysis of committed progenitors in BM: CLPs, CMPs, GMPs, and
(D) Analysis of megakaryocytic markers (CD41, CD61, and CD42d) in B
(E) Analysis of T cell (CD3+) in thymus and PB (n = 6–11 different mi
(F) Thymocytes at late stages of maturation were analyzed by stainin
(CD4+CD8–), CD8+ SP (CD4–CD8+) (n = 7–9 different mice). Representati
indicate the percentage of cells in each region.
See also Figures S2 and S3.
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reports (Nakahira et al., 2007; Mulroy et al., 2003).
PTPN13 and b-Catenin Regulate HSC Proliferation
and Quiescence
The reduced number of GFP+ cells within the Lin– fraction
when b-catenin or PTPN13 were downregulated could be
explained in terms of a lower proliferation rate. To test
this possibility, the proportion of Lin– cells in G0/G1 was
analyzed. Our results revealed a mild but significant in-
crease in cells in G0/G1 phase when b-catenin or PTPN13
were downregulated (Figure 3A), suggesting an increase in
the frequency of non-proliferating cells. To test this further,
we studied the percentage of positive cells for the prolifer-
ation marker Ki67; the number of proliferating cells was
significantly reduced in Lin– cells and in all the subpopula-
tions of HSCs (LSKs, LMPPs, ST-HSCs, and LT-HSCs) upon
PTPN13 or b-catenin silencing (Figure 3B). Cell-cycle activ-
ity must be strictly regulated in HSCs, and the balance
between proliferation and quiescence is important to
ensure hematopoiesis (Pietras et al., 2011). The lower num-
ber of proliferating cells suggested that PTPN13 or b-cate-
nin silencing might increase quiescence within the HSC
compartment. To test this, we analyzed the proportion of
quiescent cells by pyronin Y staining experiments (Schmid
et al., 2000). Our results showed that PTPN13 or b-catenin
downregulation increased the proportion of quiescent cells
within the LT-HSC and ST-HSC subpopulations (Figure 3C).
Thus, our results suggested that PTPN13 and b-catenin
would be involved in controlling the balance between
the proliferation and quiescence of HSCs.
PTPN13 and b-Catenin Regulate HSC Attachment
to the Bone Marrow Niche
The balance between quiescence and proliferation is
determined by intrinsic and extrinsic factors (Li and Bhatia,
2011), the anchorage of HSCs to the BM (Smith-Berdan
et al., 2011) being especially important since it can
contribute to the maintenance of LT-HSC quiescence
(Yoshihara et al., 2007). We therefore wondered whether
the capacity for attachment to the BM niche was affected
by PTPN13 or b-catenin levels. BM cells were obtained by
bone flushing. Subsequently, the bones were subjected toMEP (n = 9–12 different mice).
M (n = 4–8 different mice).
ce).
g with CD4- and CD8-specific antibodies: DP (CD4+CD8+), CD4+ SP
ve flow cytometry diagrams are shown. Numbers next to boxed areas
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Figure 3. PTPN13 or b-Catenin Silencing Reduces HSC Cycling and Increases Quiescence
In vivo analysis of BM progenitors in mice transplanted with Lin– control cells (Luc RNAi) or Lin– cells knocked down for PTPN13 or
b-catenin.
(A) Lin– cells were stained with 7AAD and the frequency of cells in G0/G1 was analyzed by flow cytometry (n = 4–6 different mice).
A representative diagram is shown.
(B) The percentage of Ki67+ proliferating cells was analyzed in different subpopulations of progenitor cells (n = 6–8 different mice).
(C) LT-HSCs and ST-HSCs quiescence was analyzed by PY/7AAD staining. The downregulation of PTPN13 or b-catenin increases the pro-
portion of quiescent cells. A representative experiment is shown.
Means ± SD are shown.digestion with collagenase/dispase to release the cells
that were strongly attached to the bone. The percentage
of Lin– and LSKs within the GFP+ gated cells were analyzed
in both fractions. The frequency of GFP+ Lin– and GFP+
LSKs adhered strongly to the bone was greater in theStem Cellmice in which PTPN13 or b-catenin had been downre-
gulated (Figure 4A). In control mice, the percentages of
LSK cells in both fractions were very similar, but upon
PTPN13 or b-catenin downregulation an increase of
1.7- and 2.35-fold occurred, respectively, in the percentageReports j Vol. 5 j 516–531 j October 13, 2015 j ª2015 The Authors 521
of LSKs strongly attached to the bone when compared
to the BM flushed fraction. Histological analysis failed to
reveal any obvious differences in the localization at the
BM between cells downregulated for PTPN13 or b-catenin
in comparison with control cells (Figure S4).
These results suggested that the levels PTPN13 and b-cat-
enin might regulate cell adhesiveness. To test this further,
PTPN13 or b-catenin was silenced in HEL cells (Figures 4B
and 4C). The capacity of adhesion to collagen- and fibro-
nectin-coated plates was increased following the silencing
of either protein (Figure 4D). The expressionof ten different
CAMs was analyzed by qRT-PCR. The expression of several
of these genes (ITGA4, CDH1, CDH12, NCAM2, and RELN)
was upregulated upon PTPN13 or b-catenin downregula-
tion (Figure 4E), which could account for the higher adhe-
siveness of these cells. This change in expression could be
explained whether these genes were b-catenin transcrip-
tional targets. To test this hypothesis, the activity of the
CDH1 gene promoter was analyzed (Figure 4F). b-catenin
overexpression reduced CDH1 promoter activity, support-
ing the notion that b-cateninmay control the transcription
of the CAMs-coding genes referred above.
Regulation of b-Catenin and PTPN13 Levels by
Cellular Signaling
b-catenin levels are strictly regulated by extracellular
signaling, and PTPN13 is involved in this regulation, pre-
venting b-catenin degradation (Sardina et al., 2014). We
therefore wondered whether the levels of these two pro-
teins could be regulated by signals emanating from the
BM niche. To test this idea, we first used a conditioned
medium derived from immortalized bone marrow mesen-
chymal stroma cells (hMSC-TERTs) (Mihara et al., 2003).
This conditioned medium induced a striking downregula-
tion of PTPN13 and b-catenin in HEL cells (Figure 5A).
With this treatment, the cells became adherent (Figure S5),
which could be explained in terms of the observed altered
expression of CAMs (Figure 5B). These results suggested
that PTPN13 and b-catenin levels could be regulated by
signals emanating from the niche, which in the long run
would regulate cell adhesion capacity through control of
CAMs expression.
To test this further, we next investigated the effect of
several cytokines that have been implicated previously in
the regulation of HSCs such as Wnt (Reya et al., 2003;
Florian et al., 2013), TPO (Qian et al., 2007; Yoshihara
et al., 2007; Sanjuan-Pla et al., 2013), CXCL-12 (Sugiyama
et al., 2006), and SCF (Kent et al., 2008). Wnt, TPO, and
CXCL12 increased PTPN13 and b-catenin levels, while
SCF decreased their levels (Figures 5C and 5D). In sum,
PTPN13 and b-catenin levels are modulated by different
cytokines involved in the regulation of HSCs. Moreover,
we observed that some of the CAMs that were upregulated522 Stem Cell Reports j Vol. 5 j 516–531 j October 13, 2015 j ª2015 The Aby PTPN13 or b-catenin silencing were downregulated
by Wnt, TPO, or CXCL12 signaling (ITGA4, NCAM2, or
CDH1), while SCF signaling exerted the same effect as
PTPN13 or b-catenin silencing on the expression of ITGAL
and NCAM2 (Figure 5E).
b-Catenin and PTPN13 Downregulation Increases the
Adhesiveness of Hematopoietic Progenitor Cells
The increased adhesion of HSPCs to the bone in vivo
(Figure 4A) could be explained by an increased adhesive-
ness of these cells upon PTPN13 and b-catenin downregu-
lation, as we observed for HEL cells (Figure 4D; Figure S4).
To test this further, we analyzed the adhesion capacity of
BM mouse progenitor cells in vitro. Two different sources
of HSPCs obtained from the transplanted animals were
used: the Lin– fraction (Figure 6A), purified after the BM,
and the hematopoietic cells that were more strongly
attached to the bone, obtained after digestion with colla-
genase and dispase (Figure 6B). We observed increased
adhesion to collagenwith both sources of cells upon down-
regulation of PTPN13 or b-catenin. Similar results were
found for adhesion to fibronectin. We then analyzed the
capacity for adhesion to mouse mesenchymal stroma cells
(mMSCs), and in these we also found that the ability HSPCs
to adhere to these niche cells was also enhanced by PTPN13
or b-catenin downregulation (Figures 6A and 6B).
Given that our results suggest that PTPN13 and b-catenin
levels might be regulated by niche signals, we considered
that it was worth analyzing whether the adhesiveness
of HSPCs might be regulated by niche signals. In fact,
the adhesion of Lin– cells to collagen and fibronectin
was significantly enhanced by treatment with mesen-
chymal cell-conditioned medium (Figure 6C). Moreover,
we observed a significant decrease in PTPN13 mRNA (Fig-
ure 6D). Although there was no a clear reduction in b-cate-
nin mRNA levels, it is likely that the downregulation of
PTPN13 would cause a decrease in b-catenin protein levels,
as we have shown previously (Sardina et al., 2014). Finally,
we observed an upregulation of several CAMs (Itgal,Ncam2,
and Cdh1) in the hematopoietic progenitors treated with
mesenchymal cell-conditioned medium (Figure 6E), which
could account for the increased adhesiveness (Figure 6C).
In sum, these experiments show that, as was the case for
HEL cells, the adhesion capacity of hematopoietic progen-
itors is altered by PTPN13 and b-catenin downregulation,
a process that might be regulated by signaling from the
BM niche.
Functional Implications of PTPN13 or b-Catenin in
the Regulation of Hematopoietic Progenitors by the
BM Niche
Our in vivo analysis revealed that the downregulation of
PTPN13 and b-catenin reduced cell cycling and increaseduthors
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(legend on next page)
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the quiescence of HSCs (Figure 3). We surmised that this
might be related to the increased adhesiveness of these
cells to the niche. To test this hypothesis, the quiescence
and cell cycling of Lin– progenitors were analyzed under
in vitro culture conditions and in co-culture with mMSCs.
During in vitro culture, no differences were observed be-
tween Lin– cells downregulated for PTPN13 or b-catenin
and control cells regarding cell cycling (Figures 7A and
7B), or quiescence (Figure 7C). However, upon co-culture
with mMSCs the cells downregulated for PTPN13 and
b-catenin showed a significant decrease in cell cycling
and an increase in quiescence in comparison with control
cells, as seen from the decrease in Ki67 marker (Figure 7A)
and the reduced incorporation of BrdU (Figure 7B), and
by the increase in PY staining (Figure 7C), respectively.
Strikingly, when the co-culture experiments were per-
formed using transwell devices, no effects were found, sug-
gesting that the above changes regarding cell cycling and
quiescence would require direct cell-cell contact between
HSPCs and mMSCs.DISCUSSION
Understanding the mechanisms that govern the balance
between self-renewal and differentiation or between cell-
cycle progression andquiescence inHSCs is essential. These
processes are regulated by the different signals received by
HSCs from the BMniche. Accordingly, it is crucial to under-
stand how these inputs are processed by HSC intracellular
signaling. In this work, we show that the levels of PTPN13
and b-catenin are important for regulatingHSCsquiescence
and cell adhesiveness, and our results suggest that the
regulation of the levels of these two proteins by different
extracellular signaling pathways might be essential for the
regulation of HSC biology. Moreover, in agreement with
previous reports (Sardina et al., 2014; Nakahira et al.,
2007; Mulroy et al., 2003; Xu et al., 2003), our results also
suggest the involvement of these two proteins in mega-
karyocytic and lymphoid maturation. In future studies,
we shall analyze this issue in greater depth.Figure 4. PTPN13 or b-Catenin Silencing Increases Cell Adhesiven
(A) The proportion of Lin–(CD45+Lin–) and LSKs (CD45+Lin–c-KIT+SCA1
BM had been flushed out (n = 4–5 different mice). The frequency of Lin
PTPN13 or b-catenin had been silenced.
(B and C) PTPN13 or b-catenin was silenced in HEL cells. The levels
experiments) (B) and immunoblotting (n = 3 independent experimen
(D) Cell adhesiveness to collagen- or fibronectin-coated plates was a
(E) The expression of several genes coding for CAMs was analyzed by
(F) CDH1 promoter activity was analyzed by luciferase reporter assay i
S33Y) (n = 4 independent experiments).
Means ± SD are shown. See also Figure S4.
524 Stem Cell Reports j Vol. 5 j 516–531 j October 13, 2015 j ª2015 The AThe in vivo silencing of PTPN13 or b-catenin reduced
the total number of engrafted GFP+ cells in BM. However,
it led to an increased frequency of both GFP+ LT-HSCs
and GFP+ ST-HSCs. HSCs have a low proliferation rate (Pie-
tras et al., 2011), and hence the enrichment in HSCs would
explain the reduced number of engrafted GFP+ cells upon
PTPN13 or b-catenin downregulation. This was confirmed
by analysis of the Ki67 proliferation marker, which was
significantly reduced in all progenitor subpopulations
when compared to control cells. This is in agreement
with the increase in quiescence detected in the GFP+ LT-
HSCs and GFP+ ST-HSCs.
Nevertheless, these observations did not explain why
the frequency of HSCs and their quiescence was increased
upon downregulation of PTPN13 or b-catenin. Consid-
ering the involvement of b-catenin in the cell adhesion
process (Valenta et al., 2012), we thought it worthwhile
to study whether attachment to the BM was altered. Sur-
prisingly, our in vivo data showed a higher adhesion of
mouse progenitor cells to the BM niche upon PTPN13
or b-catenin downregulation. These results are in agree-
ment with many in vitro data that we report showing
the alteration of cell adhesion when PTPN13 or b-catenin
levels are modified, both in HEL cells and in also in
murine hematopoietic progenitor cells. We therefore
wondered whether the expression of genes coding for
CAMs was altered. The expression of ten different genes,
most of them expressed in HSCs (Prowse et al., 2011),
was monitored in a cell line downregulated for PTPN13
or b-catenin. Interestingly five of these genes (ITGA4,
CDH1, CDH12, NCAM2, and RELN) were upregulated;
no differences were found in one of them (ITGA5), and
only three of them were downregulated (ITGA11, ITGAL,
CDH5). These dramatic changes at the cell surface could
ultimately account for the increased adhesiveness. It has
been reported previously that b-catenin suppresses the
expression of cadherin genes (Jamora et al., 2003). Our
analysis of CDH1 gene promoter activity allows us to pro-
pose that some of the CAMs coding genes may be b-cate-
nin transcriptional targets, while PTPN13, preserving
b-catenin stability (Sardina et al., 2014), would contributeess and the Upregulation of Cell Membrane Adhesion Molecules
+) cells was analyzed in collagenase-/dispase-digested bones after
– and LSKs strongly attached to the bone was higher in mice in which
of expression were analyzed by qRT-PCR (n = 5 or 8 independent
ts) (C).
nalyzed in these cells (n = 5–7 independent experiments).
qRT-PCR (n = 4–9 independent experiments).
n the presence or absence of a b-catenin stable mutant (b-catenin
uthors
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Figure 6. Increased Adhesion of Mouse BM Progenitor Cells by PTPN13 or b-Catenin Silencing or by Treatment with Mesenchymal
Cell-Conditioned Medium
(A) Lin– progenitor cells were purified after flushing the BM of the transplanted animals (n = 4–5 different mice).
(B) The hematopoietic cells that remained attached to the bone were obtained after collagenase/dispase digestion (n = 4–9 different
mice). Both sources of cells were seeded in collagen- or fibronectin-coated plates, or in a monolayer of mouse mesenchymal stroma cells
(mMSCs). 4 hr later, non-adherent cells were removed by gentle washing with PBS. The relative adhesion was monitored by comparing the
percentage of GFP+ adhered cells to the initial % GFP+ cells.
(C) Adhesion to collagen- or fibronectin-coated plates of Lin– cells treated with mesenchymal cell-conditioned medium (MC-CM) or with
control medium during 4 hr (n = 3 independent experiments).
(D) Messenger levels for PTPN13 and b-catenin in Lin– cells treated with MC-CM or control medium during 8 hr.
(E) Messenger levels for several genes coding for CAMs treated with MC-CM or control medium during 8 hr (n = 5 independent experiments).
Upregulated genes are shown in blue, and downregulated genes are in yellow. Means ± SD are shown.to the transcriptional regulation of these genes. The
biology of stem cells depends on their relationship with
the niche, and it is clear that CAMs would play a leading
role in this respect. For example, it is well known that
CDH1 is required for the survival and self-renewal of
hESCs (Li et al., 2012), and to maintain HSC multipo-
tency in Drosophila (Gao et al., 2013). Recent reportsFigure 5. PTPN13 and b-Catenin Are Targets of Several Signaling
(A and B) HEL cells were treated with mesenchymal cell-conditioned
messenger (A) and the levels of several genes coding for CAMs were an
with 100 ng/ml Wnt3a, 100 ng/ml TPO, 100 ng/ml CXCL-12 or 100 ng
(C) PTPN13 and b-catenin messenger levels (n = 4–5 independent ex
(D) PTPN13 and b-catenin proteins levels (n = 3–5 independent expe
(E) Expression of several genes coding for CAMs (n = 4–6 independent
and protein levels were monitored at different time points.
In (B) and (E), upregulated genes are shown in blue, and downregula
526 Stem Cell Reports j Vol. 5 j 516–531 j October 13, 2015 j ª2015 The Ashow that CDH1 overexpression enhances the generation
of induced pluripotent stem cells (iPS) (Chen et al., 2010),
or the conversion from primed to naive-like pluripotent
stem cells (PSCs) (Murayama et al., 2015). Moreover, it
has recently been shown that a low expression of Itgal
is linked to HSC long-term reconstitution capacity (Fath-
man et al., 2014).Pathways
medium (MC-CM). The levels of PTPN13 and b-catenin protein and
alyzed (B) (n = 4 independent experiments). HEL cells were treated
/ml SCF, and the following parameters were analyzed.
periments).
riments).
experiments). Messenger levels were analyzed after 8-hr treatment,
ted genes are in yellow. Means ± SD are shown. See also Figure S5.
uthors
AB
C
D
Figure 7. PTPN13 or b-Catenin Silencing Reduces HSC Cycling
and Increases Quiescence
Lin– cells were transduced in vitro with lentiviruses carrying shRNAs
against PTPN13, b-catenin, or luciferase as a control, as depicted in
Stem CellWe believe that the alteration of cell adhesion capacity
may have important functional consequences, explaining
the differences that we observed in the cell cycling
and quiescence of hematopoietic progenitors. Supporting
this notion, here we show that the downregulation of
PTPN13 or b-catenin significantly reduces cell cycling
and increases the quiescence of Lin– progenitor cells co-
cultured with mMSCs. It is worth noting that this effect
is attained by direct cell-cell contact, since no effects
were seen during transwell co-culture experiments. In
short, we propose that the greater adhesiveness would
be responsible for the reduced proliferation and increased
quiescence upon PTPN13 and b-catenin downregulation
observed in the in vivo experiments, in agreement with
previous studies showing that quiescent cells are tightly
bound to the BM niche (Scott et al., 2003). Osteoblast
seem to play a key role in the maintenance of HSC quies-
cence (Bowers et al., 2015), which may be related to a
physical contact between osteoblast and HSCs (Zhang
et al., 2003). Here, we show that the interaction with
mesenchymal stroma cells might be also important for
the regulation of HSC quiescence. Accordingly, we specu-
late that different types of niche cells might cooperate to
maintain such quiescence.
We surmise that b-catenin and PTPN13 must be impor-
tant for integrating the different signals received from
the niche. Our results support this notion, since treatment
with mesenchymal cell-conditioned medium led to the
downregulation of PTPN13 and b-catenin, together with
an increase in cell adhesiveness that could be explained by
the change in CAM expression. The relevance of b-catenin
in the context of cellular signaling has also been suggested
for other types of stemcells (Murphy et al., 2014; Lindstro¨m
et al., 2015). The fact that PTPN13 and b-catenin levels were
modified by several cytokines (Wnt3a, TPO, CXCL12, andFigure S1B. Cells were cultured in control medium or upon co-cul-
ture with mMSCs with or without a transwell device during 48 hr.
The following parameters were analyzed in the three different
culture conditions.
(A) Percentage of Ki67+ proliferating cells (n = 4 independent
experiments).
(B) Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) incorpo-
ration to replicating cells after 16 hr of BrdU treatment (n = 5 in-
dependent experiments).
(C) Cell quiescence estimated by PY/7AAD staining (n = 4 inde-
pendent experiments).
(D) Proposed model for PTPN13 and b-catenin as regulators of
intracellular signaling in HSPCs. PTPN13 and b-catenin can be
regulated by cytokine signaling. Low levels of these proteins would
increase HSPCs attachment to the niche through the upregulation
of CAMs. A stronger attachment to the niche would reduce cell
cycling and increase the quiescence of HSPCs.
Means ± SD are shown.
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SCF) suggests to us that these two proteins could be tar-
gets of multiple signaling pathways emanating from the
niche. CXCL12 andWnt can synergize for the stabilization
of b-catenin in cancer cells (Mo et al., 2013). SCF reinforces
TPO signaling in megakaryocyte progenitors (Drayer et al.,
2005). Regarding our results, it is feasible that different
signaling pathways would converge at the level of PTPN13
and b-catenin, and hence these proteins would contribute
to the integration of these signals by HSPCs.
The use of HSCs in regenerative medicine is of para-
mount importance (Felfly and Haddad, 2014). Bearing in
mind our results, we suggest that PTPN13 and b-catenin
might be interesting therapeutic targets, since the modifi-
cation of their levels could facilitate the mobilization of
HSCs from donors or favor engraftment in recipients.
In conclusion, we show that the modulation of PTPN13
and b-catenin levels must play an essential role in the regu-
lation of HSC adhesiveness, quiescence, and proliferation.
Our data are consistent with the notion that the levels
of PTPN13 and b-catenin must be kept low in order to pre-
serveHSC quiescence and attachment to the niche.We also
show that the levels of these two proteins are modified by
different signals that are important for HSC development,
such as Wnt, TPO, CXCL-12, and SCF. We propose that
the modulation of PTPN13 and b-catenin levels in HSC
would be of paramount importance for the integration of
such signals (Figure 7D).EXPERIMENTAL PROCEDURES
Cell Lines
HEL cells were grown in RPMI medium supplemented with 10%
FBS, 100 U/ml penicillin, 100 U/ml streptomycin, and 2 mM
L-glutamine. HEK293T cells and immortalized human bone
marrow stroma cells (hMSC-TERTs) were grown inDMEMmedium
supplemented with 10% FBS, 100 U/ml penicillin, 100 U/ml strep-
tomycin, and 2 mM L-glutamine (Mihara et al., 2003). Mesen-
chymal cell conditioned medium (MC-CM) was harvested after
72 hr, centrifuged, and filtered.
qRT-PCR
RNA was extracted with TRI reagent (Sigma) or with an RNAspin
mini kit (GE Healthcare Life Sciences). The RevertAid M-MuLV ret-
rotransciptase (Fermentas) or theGeneChipWTTerminal Labeling
Kit (Affymetrix) was used to generate cDNA. qPCR was carried out
using the Go-Taq qPCR master mix (Promega) in a StepOne Real-
Time PCR System (Applied Biosystems). Analysis of PCR data was
performed by the comparative CT method (DDCT) (Schmittgen
and Livak, 2008), using actin as an endogenous control. Oligonu-
cleotide sequences are provided as Supplemental Information.
Animals
C57BL/6 mice were obtained from Charles River Laboratories and
from the University of Salamanca Animal Facility Unit. All mice528 Stem Cell Reports j Vol. 5 j 516–531 j October 13, 2015 j ª2015 The Awere kept at the pathogen-free animal facilities of University of
Salamanca and were monitored daily. All experiments carried out
on animals were approved by the Bioethics Committee of the Uni-
versity of Salamanca.
Lentiviral Production for RNA Interference
The expression of PTPN13 and b-catenin was reduced by lentiviral
infection with specific small hairpin RNAs (shRNA). An oligonu-
cleotide against firefly luciferase was used as a control, as previ-
ously described (Sardina et al., 2010, 2014; Sa´nchez-Sa´nchez
et al., 2014).
Bone Marrow Cell Purification and Lentiviral
Transduction
BM cells were flushed with RPMI medium from femurs and tibias.
Preparations were filtered to remove debris and washed twice in
phosphate-buffered saline. Lin– cells were purified with the Line-
age Cell Depletion Kit for mice (MiltenyiBiotec), according to the
manufacturer’s instructions. Lin– cell lentiviral transduction was
performed as described (Sardina et al., 2014).
Bone Marrow Transplantation
Syngenic C57BL/6 recipient mice received two doses of 5Gy,
separated in time by 2 hr, from a Cs source (Gammacell 1000
Elite, Nucleus Facility, University of Salamanca), and were trans-
planted 6 hr after the second irradiation. 3 3 105 of unsorted
lentiviral transduced Lin– cells were injected intravenously
through a tail vein of recipients, 24 hr after spinoculation.
shRNA-carrying cells were identified by GFP expression. In vivo
hematopoiesis was followed over 8 weeks after transplantation.
A schematic representation of the experimental setting can be
seen in Figure S1B.
Flow Cytometry
The lineage-specificmarkers usedwere as follows: CD41, CD61, and
CD42d formegakaryocytes; Ter119 for erythrocytes;Gr1andCD11b
for granulocytes and macrophages; CD19 and B220 for B cells,
and CD3 for T cells. B cell maturation was analyzed in BM:
ProB (B220+CD43+IgM–), PreB (B220+CD43–IgM–), and ImmBcells
(B220+CD43–IgM+). T cell maturation was analyzed in the thymus:
DN1 (CD44+CD25–), DN2 (CD44+CD25+), DN3 (CD44–CD25+),
and DN4 (CD44–CD25–). DN (CD4–CD8–), DP (CD4+CD8+),
CD4+ SP (CD4+CD8–), CD8+ SP (CD4–CD8+); BM Lin– cell subpop-
ulations were identified as follows: LSKs (Lin–c-KIT+SCA1+),
LT-HSCs (Lin–c-KIT+SCA1+CD34–FLT3–), ST-HSCs (Lin–c-KIT+
SCA1+CD34+FLT3–), LMPPs (Lin–c-KIT+SCA1+CD34+FLT3+), CMPs
(Lin–c-KIT+SCA1–CD34+CD16/32–), CLPs (Lin–c-KITlo, SCA1loIL-7-
Ra–), MEPs (Lin–c-KIT+SCA1–CD34–IL-7-Ra–CD16/32–), GMPs
(Lin–c-KIT+SCA1–CD34+ IL-7-Ra–CD16/32+). Fluorescence minus
one (FMO) controls were used for fluorescence-activated cell
sorting (FACS) gating optimization (Maecker and Trotter, 2006).
The number of quiescent LT-HSCs was analyzed by staining of
the Lin– fraction with specific surface markers, together with
1 mg/ml pyronin Y (PY), 10 mg/ml 7ADD and 10 mg/ml ADD,
as previously described (Schmid et al., 2000). Bromodeoxyur-
idine (5-bromo-2-deoxyuridine, BrdU) incorporation was per-
formed with the APC BrdU Kit (BD Biosciences), following theuthors
manufacturer’s instructions. The results were analyzed with the
FACS Flowing 2 and Infinicyt Programs.
Isolation of Bone-Associated Cells
BM cells were fully flushed from the femurs and tibias of trans-
planted animals. The bones were then digested with 0.02 mg/ml
collagenase/dispase (Roche) for 2 hr at 37C with constant agita-
tion. Flushed BM cells and collagenase-/dispase-digested bones
were analyzed by flow cytometry to determine the percentage of
LSK cells (CD45+Lin–c-KIT+SCA1+) in each fraction.
In Vitro Adhesion Assays
Cell adhesiveness was monitored in 100 mg/ml collagen- or
20 mg/ml fibronectin-coated plates. Cells were seeded for 3 hr at
37C and washed twice with PBS, and the proportion of adhered
cells was measured with the MTT assay (Sa´nchez-Sa´nchez et al.,
2014) in the case of HEL cells, or by evaluating the % of GFP+ cells
by flow cytometry in the case of BM primary cells.
CDH1 Promoter Luciferase Reporter Assay
CDH1 promoter activity was analyzed in 293T with the reporter
plasmid pGL-E-Cad (427+53) (Lee et al., 2011) in the absence
or presence of a plasmid overexpressing a b-catenin stable mutant
(pWPI-b-cateninS33Y). Luciferase activity was normalized with
respect to b-galactosidase transfection control as described (Sar-
dina et al., 2014).
Isolation of Mouse Mesenchymal Stromal Cell
BM was harvested from femurs of 8- to 10-week old C57BL/6 mice
by flushing with RPMI medium. The cells were resuspended after
washing in complete MesenCult medium (STEMCELL Technolo-
gies) and cultured at 37C and 5% CO2. Non-adherent cells were
removed after 72–96 hr in culture; adherent cells were harvested
by trypsinization (0.05% trypsin-EDTA, GIBCO Invitrogen) when
90% confluence had been reached, after which they were replated.
The medium was changed every 3–4 days. For co-culture assays,
mMSC were used at passage 3–5.
Immunohistochemical Analysis
Immunohistochemical analysis on femurs sections was performed
as described before (Carrancio et al., 2011). shRNAs modified cells
were identified by GFP expression with a rabbit monoclonal
anti-GFP antibody (AbCam). Primary antibody was revealed using
a biotinylated secondary antibody and the ABC kit (Vector Labora-
tories) with Diaminobenzime (DAB, Sigma-Aldrich). Finally, slides
weremounted and observedwith anOlympus BX41TFmicroscope
(Olympus Optical).
Statistical Analyses
Statistical analyses were performed using Student’s t test. Differ-
ences were considered statistically significant when p < 0.05.
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